Multiple Dose, Steady State-Partial reference replicate [Design Issues]

posted by ElMaestro  – Denmark, 2018-07-13 15:42 (2106 d 21:06 ago) – Posting: # 19047
Views: 3,996

Hi arl_stat,

❝ Please help in understanding whether it is possible to conduct “An open-label, randomized, Multiple Dose, Steady State, two treatments, three periods, three sequence, three way, Reference Replicated crossover bioequivalence study” for USFDA Submission?


Yes to everything except (conditionally) the term 'three way' in the context of your post.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,987 posts in 4,824 threads, 1,661 registered users;
73 visitors (0 registered, 73 guests [including 3 identified bots]).
Forum time: 12:48 CEST (Europe/Vienna)

The only way to comprehend what mathematicians mean by Infinity
is to contemplate the extent of human stupidity.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5